MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Browse and search for drug monographs and related information

Approved pharmaceutical products by global regulatory authorities

Explore a comprehensive list of organizations, including their profiles and details

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 540901 clinical trials

Sort by:

Use of PRP in Open Surgery for Type A Aortic Dissection

Phase 2

Not yet recruiting

Conditions: Aortic Dissection Type A
Transfusions
Platelet Rich Plasma (PRP)
Organ Protection

Interventions: Biological: Autologous Platelet Rich Plasma
Procedure: Standard Blood Management

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Beijing Anzhen Hospital

Target Recruit Count: 250

Registration Number: NCT07005661

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

Phase 3

Not yet recruiting

Conditions: Small-cell Lung Cancer
Extensive Stage Small-cell Lung Cancer

Interventions: Drug: Tarlatamab
Drug: Durvalumab
Drug: Carboplatin
Drug: Etoposide

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Amgen

Target Recruit Count: 330

Registration Number: NCT07005128

HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women

Not Applicable

Not yet recruiting

Conditions: Endometriosis

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 100

Registration Number: NCT07006987

Locations: 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Phase 2

Not yet recruiting

Conditions: Triple-Negative Breast Cancer (TNBC)

Interventions: Drug: QL1706 Plus Olaparib

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Tianjin Medical University Cancer Institute and Hospital

Target Recruit Count: 46

Registration Number: NCT07005583

Locations: 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders

Completed

Conditions: Schizophrenia and Schizoaffective Disorder
Bipolar Disorder (BD)

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Peking University

Target Recruit Count: 77145

Registration Number: NCT07005245

Locations: 🇨🇳
Peking University Sixth Hospital, Beijing, Haidian District, China

Long COVID Cutaneous Signatures: An ARPA Funded Research Project

Recruiting

Conditions: Long COVID
Acute COVID-19
Postural Orthostatic Tachycardia Syndrome (POTS)
Diabetic Neuropathy

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: CND Life Sciences

Target Recruit Count: 300

Registration Number: NCT07005947

Locations: 🇺🇸
CND Life Sciences, Scottsdale, Arizona, United States

Cardiac Rehabilitation in Coronary Artery Bypass Graft Surgery

Not Applicable

Recruiting

Conditions: Coronary Artery Bypass Graft Surgery
Coronary Artery Disease

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Atlas University

Target Recruit Count: 30

Registration Number: NCT07006441

Locations: 🇹🇷
Istanbul Atlas University, Istanbul, Turkey

Can the Ergometric Test in Flu-like Syndrome Help in the Outcome Analysis of Unvaccinated Patients

Recruiting

Conditions: Flu-like Syndrome
FLU
Flu-like Symptoms
Vaccination

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: University of Sao Paulo

Target Recruit Count: 150

Registration Number: NCT07007377

Locations: 🇧🇷
Clínica Pró-Coração, Sao Paulo, SP, Brazil

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

Phase 1

Not yet recruiting

Conditions: IDH1-Mutated Malignancies

Interventions: Drug: Ivosidenib Oral Tablet

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Servier Bio-Innovation LLC

Target Recruit Count: 30

Registration Number: NCT07006688

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Phase 1

Not yet recruiting

Conditions: Relapsing Multiple Sclerosis (RMS)
Progressive Multiple Sclerosis (PMS)
Multiple Sclerosis - Relapsing Remitting
Multiple Sclerosis
Multiple Sclerosis (Relapsing Remitting)
Multiple Sclerosis (MS) - Relapsing-remitting
Progressive Multiple Sclerosis

Interventions: Biological: CABA-201

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-05

Lead Sponsor: Cabaletta Bio

Target Recruit Count: 12

Registration Number: NCT07006805

Prev
1
66
67
68
69
70
100
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy